Literature DB >> 334305

Cardiovascular actions of prostacyclin (PCI2) in chloralose anaesthetized dogs [proceedings].

J M Armstrong, D Chapple, G J Dusting, R Hughes, S Moncada, J R Vane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 334305      PMCID： PMC1667682     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  4 in total

1.  Continuous measurement of peripheral vascular resistance and circulatory function.

Authors:  R Hughes
Journal:  Med Biol Eng       Date:  1971-11

2.  Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation.

Authors:  S Bunting; R Gryglewski; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1976-12

3.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

4.  Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid.

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1977-01
  4 in total
  10 in total

1.  Activated neutrophils impair gastric cytoprotection role of neutrophil elastase.

Authors:  N Harada; K Okajima; W Liu; M Uchiba
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

2.  Lungs as a generator of prostacyclin--hypothesis on physiological significance.

Authors:  R J Gryglewski; R Korbut; A Ocetkiewicz; J Spławiński; B Wojtaszek; J Swies
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-08       Impact factor: 3.000

Review 3.  The kallikrein-kinin system in circulatory and metabolic homeostasis.

Authors:  R McConn; G L Haberland; J C Frölich
Journal:  World J Surg       Date:  1981-07       Impact factor: 3.352

4.  Effect of sodium removal on tension and membrane potential after inhibition of the sodium pump in dog Purkinje fibres.

Authors:  E Coraboeuf; P Gautier; P Guiraudou
Journal:  J Physiol       Date:  1978-08       Impact factor: 5.182

5.  Prostaglandin formation from exogenous precursor in homogenates of human cardiac tissue.

Authors:  R Brandt; J Nowak; T Sonnenfeld
Journal:  Basic Res Cardiol       Date:  1984 Mar-Apr       Impact factor: 17.165

6.  Disappearance of prostacyclin (PGI2) in the circulation of the dog [proceedings].

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

7.  Recirculation of prostacyclin (PGI2) in the dog.

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

8.  Some direct and reflex cardiovascular actions of prostacyclin (PGI2) and prostaglandin E2 in anaesthetized dogs.

Authors:  D J Chapple; G J Dusting; R Hughes; J R Vane
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

9.  Coronary vasodilation: interactions between prostacyclin and adenosine.

Authors:  K E Blass; W Förster; U Zehl
Journal:  Br J Pharmacol       Date:  1980-08       Impact factor: 8.739

10.  Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension.

Authors:  G M Tozer; R J Maxwell; J R Griffiths; P Pham
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.